Lupron depot 11.25 MG 3MO kits
Ended Awarded Last action
- Contract number
- SPE2DR26F9LS6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $76,220
Award facts
- Contract value 100% obligated
- $76,219.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $76,219.68, was awarded on January 16, 2026, to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month treatment kits. The contract is a firm fixed-price delivery order with an ultimate completion date of January 20, 2026, and represents a non-set-aside, competitively awarded contract. The Defense Logistics Agency, which funds the award, procured these pharmaceutical products for delivery to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal healthcare systems including military and veteran medical facilities.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. The parent IDC enables the company to deliver a broad range of pharmaceutical products and medical supplies supporting military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The Defense Logistics Agency's Medical Supply Chain utilizes this vehicle to fulfill critical pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9LS6?
SPE2DR26F9LS6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LS6 worth?
The government has obligated $76,220 on SPE2DR26F9LS6.
Is contract SPE2DR26F9LS6 an order under another contract?
Yes. SPE2DR26F9LS6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LS6 competed?
The extent of competition for SPE2DR26F9LS6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award